Success Metrics

Clinical Success Rate

100.0%

Based on 16 completed trials

Completion Rate

100%(16/16)

Active Trials

2(8%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

Ph phase_3

21%

Ph phase_1

21%

Ph phase_2

54%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution24 total trials

Phase 1Safety & dosage

5(20.8%)

Phase 2Efficacy & side effects

13(54.2%)

Phase 3Large-scale testing

5(20.8%)

N/ANon-phased studies

1(4.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

16 of 16 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(16)

Other(4)

Detailed Status

Completed16

unknown4

Not yet recruiting2

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 15 (20.8%)

Phase 213 (54.2%)

Phase 35 (20.8%)

N/A1 (4.2%)

Trials by Status

recruiting14%

active_not_recruiting14%

not_yet_recruiting28%

unknown417%

completed1667%

Recent Activity

2 active trials

Showing 5 of 24

completedphase_3

A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）

NCT05436275

completedphase_2

The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT05131464

View all 24 trials

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more

NCT06277765Phase 3

Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis

Completed

NCT06495229Phase 3

Study of CM310 in Adolescent Subjects With Atopic Dermatis

Active Not Recruiting

NCT05265923Phase 3

A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis

Completed

NCT05436275Phase 3

A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）

Completed

NCT05131464Phase 2

The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Completed

NCT05908032Phase 3

Study of CM310 in Subjects With Allergic Rhinitis

Completed

NCT05908721Phase 2

Study of CM310 in Patients With Allergic Rhinitis

Completed

NCT04893707Phase 2

The Study of CM310 in Patients With Atopic Dermatitis

Completed

NCT05579925Phase 2

A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

Completed

NCT05715320Phase 2

Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis

Completed

NCT06162507Phase 1

Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

Completed

NCT05702450Phase 1

Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310

Completed

NCT06547333Phase 2

A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease

Not Yet Recruiting

NCT05186909Phase 2

A Study of CM310 in Subjects With Moderate to Severe Asthma

Completed

NCT05761028Phase 2

A Study of CM310 in Subjects With Moderate to Severe Asthma

Recruiting

NCT06171048Phase 1

Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

Unknown

NCT06171074Phase 2

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

Unknown

NCT06161090Phase 1

Study of CM310 in Healthy Subjects

Completed

NCT06116565Phase 2

A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis

Not Yet Recruiting

NCT05728684Not Applicable

Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related Disease

Unknown

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 24